Skip to main content
GutCited

연구 프로세스

477 동료 심사 연구의 그림

전체 생강 아연 이눌린 커큐민 락타아제 베르베린 차전자피 비피도박테리움 롱검 비피도박테리움 락티스 비피도박테리움 비피덤 사카로마이세스 보울라디 락토바실루스 가세리 락토바실루스 플란타룸 락토바실루스 애시도필루스 부티레이트(나트륨/칼슘 부티레이트) 페퍼민트 오일 바실루스 코아굴란스 췌장효소(판크렐리파아제) 알로에 베라(내엽 젤) 알파-갈락토시다아제 소 초유 오메가-3 지방산(EPA/DHA) 비타민 A 비타민 D 프럭토올리고당(FOS) 갈락토올리고당(GOS) L-글루타민 중쇄중성지방(MCT 오일) N-아세틸시스테인(NAC)
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 8
Figure 8 Diagram

Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.

Figure 9
Figure 9 Diagram

Overview of enzymatic activities of S. boulardii relevant to intestinal infection defense, including protease secretion that degrades bacterial toxins and virulence factors.

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.

Figure 10
Figure 10 Diagram

Overview of enzymatic activities of S. boulardii relevant to intestinal infection defense, including protease secretion that degrades bacterial toxins and virulence factors.

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.

Figure 5
Figure 5 Diagram

Clinical applications of S. boulardii across various gastrointestinal conditions are summarized, reflecting its established effectiveness in acute diarrhea treatment and prevention.

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system.

Figure 6
Figure 6 Diagram

A comprehensive model of S. boulardii's multifaceted interactions with host immunity and intestinal microbiota is presented, integrating molecular and clinical evidence.

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system.

Fig. 2. Gel-like images of the lentil protein sources under non-reducing and reducing conditions obtained from Bioanalyzer using an Agilent 80 + protein chip.
Figure 3 Micrograph

Gel-like electrophoresis images compare the protein molecular weight distribution of lentil protein sources under reducing and non-reducing conditions, revealing the impact of processing methods on protein subunit composition.

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by …

Figure 1
Figure 1

Summary of systematic review findings on over-the-counter therapies for chronic constipation, synthesizing evidence from randomized controlled trials evaluating fiber supplements, osmotic laxatives, and stimulant laxatives.

Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic …

Figure 3
Figure 3 Chart

In vitro or in vivo efficacy data for the inulin hydrogel system, evaluating anti-inflammatory and anti-fibrotic effects in intestinal tissue models.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 4
Figure 4 Chart

In vitro or in vivo efficacy data for the inulin hydrogel system, evaluating anti-inflammatory and anti-fibrotic effects in intestinal tissue models.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 5
Figure 5 Chart

In vitro or in vivo efficacy data for the inulin hydrogel system, evaluating anti-inflammatory and anti-fibrotic effects in intestinal tissue models.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 6
Figure 6 Chart

Therapeutic outcome measurements from the DSS-induced colitis model treated with the inulin hydrogel, assessing colon histology, inflammatory markers, and fibrosis resolution.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 10
Figure 10 Chart

Intestinal microbiome restoration data following inulin hydrogel treatment, showing probiotic-mediated recovery of microbial diversity and beneficial bacterial populations.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 11
Figure 11 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 12
Figure 12 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 13
Figure 13 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 14
Figure 14 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 15
Figure 15 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 3
Figure 3 Diagram

Mechanistic diagram illustrating the role of ferroptosis — characterized by iron accumulation, lipid peroxidation, and ROS production — in the pathogenesis of inflammatory bowel disease and its potential as a therapeutic target.

Role of ferroptosis in the pathogenesis and as a therapeutic target of …

Figure 4
Figure 4 Diagram

Mechanistic diagram illustrating the role of ferroptosis — characterized by iron accumulation, lipid peroxidation, and ROS production — in the pathogenesis of inflammatory bowel disease and its potential as a therapeutic target.

Role of ferroptosis in the pathogenesis and as a therapeutic target of …

Figure 5
Figure 5 Diagram

Mechanistic diagram illustrating the role of ferroptosis — characterized by iron accumulation, lipid peroxidation, and ROS production — in the pathogenesis of inflammatory bowel disease and its potential as a therapeutic target.

Role of ferroptosis in the pathogenesis and as a therapeutic target of …

Figure 6
Figure 6 Diagram

Mechanistic diagram illustrating the role of ferroptosis — characterized by iron accumulation, lipid peroxidation, and ROS production — in the pathogenesis of inflammatory bowel disease and its potential as a therapeutic target.

Role of ferroptosis in the pathogenesis and as a therapeutic target of …

Figure 1 Epithelial mechanisms of vitamin D: (1) increased VDR activity is shown to repress NF-κB-dependent epithelial apoptosis pathways in experimental colitis. (2) Claudin-2 (CL-2), a paracellular cation channel involved in barrier formation, seems to
Figure 1 Diagram

Epithelial mechanisms of vitamin D in IBD, illustrating VDR-mediated NF-kB suppression, claudin-2 regulation at the paracellular barrier, and other pathways through which vitamin D influences intestinal inflammation.

Managing vitamin D deficiency in inflammatory bowel disease.

Figure 2 Approach to 25(OH)D supplementation in patients with IBD. Determining adequate daily dose as (target s-25(OH)D level – current s-25(OH)D level) µg. If target level is not reached within 3 months, administration as weekly bolus should be tried. If
Figure 2 Flowchart

Clinical algorithm for vitamin D supplementation in IBD patients, showing dose calculation based on target 25(OH)D levels, escalation to weekly bolus if targets are unmet, and malabsorption workup considerations.

Managing vitamin D deficiency in inflammatory bowel disease.

Figure 24
Figure 24 Diagram

Supplementary qualitative analysis details the range of symptom severity and frequency reported by PEI patients during structured interviews.

Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) …

20페이지 중 7페이지